CoChat

Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells

Open access
Álvarez-Palomo, Belén, García-Martinez, Iris, Gayoso, Jorge, Raya, Angel, Veiga, Anna, Abad, María Luisa, Eiras, Adolfo, Guzmán-Fulgencio, María, Luis-Hidalgo, Mar, Eguizabal, Cristina, Santos, Silvia, Balas, Antonio, Alenda, Raquel, Sanchez-Gordo, Francisco, Verdugo, Laura Ponce, Villa, Juliana, Carreras, Enric, Vidal, Francisco, Madrigal, Alejandro, Herrero, María José, Rudilla, Francesc, Querol, Sergi · 2021 · Stem Cell Research & Therapy

Published version of a preprint

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

BACKGROUND: iPSC (induced pluripotent stem cells) banks of iPSC lines with homozygous HLA (human leukocyte antigen) haplotypes (haplobanks) are proposed as an affordable and off-the-shelf approach to allogeneic transplantation of iPSC derived cell therapies. Cord blood banks offer an extensive source of HLA-typed cells suitable for reprogramming to iPSC. Several initiatives worldwide have been undertaken to create national and international iPSC haplobanks that match a significant part of a population. METHODS: To create an iPSC haplobank that serves the Spanish population (IPS-PANIA), we have searched the Spanish Bone Marrow Donor Registry (REDMO) to identify the most frequently estimated haplotypes. From the top ten donors identified, we estimated the population coverage using the criteria of zero mismatches in HLA-A, HLA-B, and HLA-DRB1 with different stringencies: high resolution, low resolution, and beneficial mismatch. RESULTS: We have calculated that ten cord blood units from homozygous donors stored at the Spanish cord blood banks can provide HLA-A, HLA-B, and HLA-DRB1 matching for 28.23% of the population. CONCLUSION: We confirm the feasibility of using banked cord blood units to create an iPSC haplobank that will cover a significant percentage of the Spanish and international population for future advanced therapy replacement strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-021-02301-0

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 a Top 30 ranking HLA-A, HLA-B, and HLA-DRB1 estimated haplotypes by % of frequency at the Spanish Bone Marrow Donor Registry. b Graphic representation of the % of frequency of the top 100 HLA-A, HLA-B, and HLA-DRB1 estimated haplotypes
Fig. 1 a Top 30 ranking HLA-A, HLA-B, and HLA-DRB1 estimated haplotypes by % of frequency at the Spanish Bone Marrow Donor Registry. b Graphic representation of the % of frequency of the top 100 HLA-A, HLA-B, and HLA-DRB1 estimated haplotypesCC BY · PubMed Central
Fig. 2 HLA haplotypes and number of units (N.) of HLA-A, HLA-B, and HLA-DRB1 homozygous found in the Spanish registry of public cord blood banks and present at least in two units. LR, low resolution; HR, high resolution
Fig. 2 HLA haplotypes and number of units (N.) of HLA-A, HLA-B, and HLA-DRB1 homozygous found in the Spanish registry of public cord blood banks and present at least in two units. LR, low resolution; HR, high resolutionCC BY · PubMed Central
Fig. 3 Estimated percentage and cumulative percentage of HLA-matched individuals in the Spanish population with a panel of 10 homozygous donors in high resolution (a) and low resolution (b). Estimated numbers of iPSC lines homozygous for HLA-A, HLA-B, and HLA-DRB1 (haplolines) to cover the Spanish population (c)
Fig. 3 Estimated percentage and cumulative percentage of HLA-matched individuals in the Spanish population with a panel of 10 homozygous donors in high resolution (a) and low resolution (b). Estimated numbers of iPSC lines homozygous for HLA-A, HLA-B, and HLA-DRB1 (haplolines) to cover the Spanish population (c)CC BY · PubMed Central
Fig. 4 Estimated cumulative percentage of matched individuals in the Spanish population considering a “beneficial match” with a panel of 10 homozygous donors from Spanish cord blood Banks in high resolution allowing for one mismatch in any of the alleles HLA-A, HLA-B, or HLA-DRB1 (1 MM) or two mismatches (2 MM)
Fig. 4 Estimated cumulative percentage of matched individuals in the Spanish population considering a “beneficial match” with a panel of 10 homozygous donors from Spanish cord blood Banks in high resolution allowing for one mismatch in any of the alleles HLA-A, HLA-B, or HLA-DRB1 (1 MM) or two mismatches (2 MM)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 41

Metadata

Authors
Álvarez-Palomo, B., García-Martinez, I., Gayoso, J., Raya, A., Veiga, A., Abad, M. L., Eiras, A., Guzmán-Fulgencio, M., Luis-Hidalgo, M., Eguizabal, C., Santos, S., Balas, A., Alenda, R., Sanchez-Gordo, F., Verdugo, L. P., Villa, J., Carreras, E., Vidal, F., Madrigal, A., Herrero, M. J., Rudilla, F., & Querol, S.
Affiliations
  • Vall d'Hebron Institut de Recerca (ES)
  • Organización Nacional de Trasplantes (ES)
  • Institut d'Investigació Biomédica de Bellvitge (ES)
  • BioCruces Health research Institute (ES)
  • Comunidad de Madrid (ES)
  • Josep Carreras Leukaemia Research Institute (ES)
  • Universitat Autònoma de Barcelona (ES)
  • Banc de Sang i Teixits (ES)
Corresponding author
Álvarez-Palomo, Belén
Venue
Stem Cell Research & Therapy
Published
2021-04-13
Volume
12
Issue
1
Pages
233-233
ISSN
1757-6512 (ISSN-L)
OpenAlex
W3153744415
Cited by
37
References
32
Citations by year
2026: 2 · 2025: 3 · 2024: 12 · 2023: 8 · 2022: 11 · 2021: 1
FWCI
2.74
Type
journal article
Language
en
Open access
Licence
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Ministerio de Ciencia, Innovación y Universidades (RTC-2017-6000-1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
Keywords
induced pluripotent stem cells, HLA matching, umbilical cord blood, allogeneic cell therapy, Spanish population, HLA mismatch, bone marrow donor registry, population coverage
MeSH terms
Blood Banks, Haplotypes, HLA Antigens, Humans, Prospective Studies, Tissue Donors, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells. https://app.cochat.ai/papers/10.1186/s13287-021-02301-0
The paper
Álvarez-Palomo, B., García-Martinez, I., Gayoso, J., Raya, A., Veiga, A., Abad, M. L., Eiras, A., Guzmán-Fulgencio, M., Luis-Hidalgo, M., Eguizabal, C., Santos, S., Balas, A., Alenda, R., Sanchez-Gordo, F., Verdugo, L. P., Villa, J., Carreras, E., Vidal, F., Madrigal, A., . . . Querol, S. (2021). Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-021-02301-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.